ORIC

Oric Pharmaceuticals (ORIC)

About Oric Pharmaceuticals (ORIC)

Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.

Details

Daily high

$9.90

Daily low

$9.46

Price at open

$9.50

52 Week High

$16.65

52 Week Low

$5.27

Market cap

670.2M

Dividend yield

0.00%

Volume

246,075

Avg. volume

518,755

P/E ratio

-5.39

Oric Pharmaceuticals News